Tomocube, a global leader in 3D label-free imaging and analysis, proudly introduces the HT-X1™ Plus, a state-of-the-art bioimaging platform designed to meet the evolving needs of biomedical ...
Why is 3D biology gaining so much attention in drug discovery and disease modeling? One of the biggest challenges in drug discovery is the high failure rate of drug candidates in clinical trials - ...
Over the past ten years, we’ve seen tremendous advances in 3D cell technologies, such as 3D in vitro models that more closely reflect morphological characteristics, cellular complexity, and physiology ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Resolve Biosciences and Zeiss today announced a collaboration to improve ...
Discover how 3D biology, automation, and AI are revolutionizing drug discovery, improving predictive accuracy, and accelerating research. My name is Oksana Sirenko, and I am a Senior Scientist at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results